IRIS
DI MARTINO, MARIA TERESA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 830
EU - Europa 706
AS - Asia 553
SA - Sud America 76
AF - Africa 36
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.210
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 794
IT - Italia 376
SG - Singapore 253
DE - Germania 87
CN - Cina 76
GB - Regno Unito 72
IN - India 60
BR - Brasile 59
FI - Finlandia 39
HK - Hong Kong 29
NL - Olanda 26
CA - Canada 24
SE - Svezia 22
JO - Giordania 21
PK - Pakistan 21
ID - Indonesia 17
ZA - Sudafrica 13
ES - Italia 12
FR - Francia 11
SA - Arabia Saudita 11
EG - Egitto 10
RU - Federazione Russa 9
BD - Bangladesh 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
CZ - Repubblica Ceca 7
IQ - Iraq 7
LT - Lituania 7
MX - Messico 7
PT - Portogallo 7
AU - Australia 6
JP - Giappone 6
AT - Austria 5
ET - Etiopia 5
IE - Irlanda 5
IR - Iran 5
LB - Libano 5
NG - Nigeria 5
CY - Cipro 4
MY - Malesia 4
PE - Perù 4
PL - Polonia 4
TR - Turchia 4
UA - Ucraina 4
VN - Vietnam 4
BG - Bulgaria 3
EC - Ecuador 3
PH - Filippine 3
RO - Romania 3
AL - Albania 2
AR - Argentina 2
CH - Svizzera 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
KR - Corea 2
LK - Sri Lanka 2
MA - Marocco 2
PS - Palestinian Territory 2
A2 - ???statistics.table.value.countryCode.A2??? 1
EE - Estonia 1
EU - Europa 1
KE - Kenya 1
NZ - Nuova Zelanda 1
OM - Oman 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 2.210
Salva come PNG Salva come JPEG
Città #
Singapore 175
Chandler 110
Ashburn 63
Munich 63
Dallas 62
Santa Clara 52
Hefei 46
Chicago 43
London 40
Turku 28
Milan 27
Lawrence 24
Princeton 24
Hong Kong 19
Rome 19
Catanzaro 17
Los Angeles 17
Amman 13
New York 13
Carbonia 12
Naples 12
Parma 12
San Nicola Manfredi 12
Helsinki 11
Boardman 10
San Francisco 10
Spezzano della Sila 10
Palermo 9
São Paulo 9
Wilmington 9
Delhi 8
Irbid 8
Cosenza 7
Des Moines 7
Kaunas 7
Madrid 7
Montreal 7
Ottawa 7
Afragola 6
Catania 6
Ercolano 6
Frankfurt am Main 6
Riyadh 6
Santo Stefano di Rogliano 6
Sezze 6
Atlanta 5
Brooklyn 5
Cape Town 5
Cardiff 5
Chennai 5
Hyderabad 5
Jeddah 5
Lucknow 5
Melito di Porto Salvo 5
Meppel 5
Olomouc 5
Sacramento 5
Seattle 5
Addis Ababa 4
Ahmedabad 4
Council Bluffs 4
Hanover 4
Islamabad 4
Johannesburg 4
Kuala Lumpur 4
Lima 4
Nicosia 4
Oristano 4
Perugia 4
Pune 4
Redmond 4
Stockholm 4
The Dalles 4
Tokyo 4
Warsaw 4
West Jordan 4
Acquaviva delle Fonti 3
Ajman 3
Amsterdam 3
Banyumas 3
Berlin 3
Bristol 3
Buffalo 3
Castrovillari 3
Charlotte 3
Chía 3
Decollatura 3
Dhaka 3
Dubai 3
Faisalabad 3
Melbourne 3
Mileto 3
Noida 3
Oxford 3
Paola 3
Quţūr 3
Redwood City 3
Richmond 3
San Antonio 3
Santo Tirso 3
Totale 1.280
Salva come PNG Salva come JPEG
Nome #
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters 381
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 107
miR-22 suppresses DNA ligase III addiction in multiple myeloma 90
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 89
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 74
Non-coding RNAs in cancer: Platforms and strategies for investigating the genomic "dark matter" 61
Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome Profiling 61
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer 60
A 46,XY Female with a 9p24.3p24.1 Deletion and a 8q24.11q24.3 Duplication: A Case Report and Review of the Literature. 58
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 58
Augmented reality (AR) in minimally invasive surgery (MIS) training: where are we now in Italy? The Italian Society of Endoscopic Surgery (SICE) ARMIS survey 57
DMET-Analyzer: automatic analysis of Affymetrix DMET Data 56
Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment 52
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 51
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 50
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 46
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 44
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 43
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 43
DmetTM genotyping: Tools for biomarkers discovery in the era of precision medicine 43
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells 42
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties 41
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 39
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 39
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 39
Mmrf-commpass data integration and analysis for identifying prognostic markers 38
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 38
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 37
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 37
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 34
An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery 34
null 31
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 31
Ethical Perspectives on Pharmacogenomic Profiling 30
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 29
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 28
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: In vitro and in vivo anti-tumor activity 26
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 24
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells 23
LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation 23
Tools in Pharmacogenomics Biomarker Identification for Cancer Patients 22
Current status of liver surgery for non-colorectal non-neuroendocrine liver metastases: the NON.LI.MET. Italian Society for Endoscopic Surgery and New Technologies (SICE) and Association of Italian Surgeons in Europe (ACIE) collaborative international survey 19
The potential role of miRNAs in multiple myeloma therapy 19
A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer 19
Hit identification of novel small molecules interfering with MALAT1 triplex by a structure-based virtual screening 19
The EASY-NET research programme: background, structure, and methodology 15
TERRA G-quadruplex stabilization behind the anti-multiple myeloma activity: Novel insights about resveratrol pleiotropic effects 15
null 4
Totale 2.319
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.664
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.664
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 0 2 5 10 5 6 7 6 9 1 0
2021/2022126 3 0 0 22 5 0 4 21 34 15 17 5
2022/2023394 55 25 28 13 45 26 6 25 49 40 55 27
2023/2024476 90 33 42 39 45 71 25 41 10 18 27 35
2024/2025876 75 20 27 37 64 119 64 55 55 21 142 197
2025/2026351 108 154 89 0 0 0 0 0 0 0 0 0
Totale 2.319